With over 20 years of experience, HyTest develops and produces high-quality immunological reagents, including monoclonal antibodies and antigens, for various clinical areas such as cardiac markers, infectious diseases, and veterinary diagnostics. Their innovative solutions help clients deliver accurate testing and advance research in fields like neuroscience and autoimmune diseases. Recently, on May 17th, 2021, HyTest was acquired by Mindray, further expanding its reach in the diagnostic industry and research communities worldwide.